Skip to main content

Table 4 Length of stay, readmission and mortality data

From: Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)

 

Atorvastatin

n= 49

Placebo

n= 51

P-value

Length of hospital stay, median (interquartile range)

5 (3, 13)

6 (4, 12)

0.598

Readmissions, number

   

Within 28 days

5

5

1.0

 

(n = 43)

(n = 46)

 

Within 1 year

7

5

0.541

 

(n = 42)

(n = 45)

 

Mortality, number of patients

   

28 days

2

2

1.0

1 year

4

4

1.0